4 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
in HF and CKD. ... in HF and CKD. ... in HFrEF on GDMT ... outcomes in HFrEF ... visualabstract #table #CVD
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
angiotensin-receptor blocker; CAD ... HFpEF, heart failure ... ejection fraction; HFrEF ... #CHF #Congestive ... #HeartFailure #
Guideline-Directed Medical Therapy (GDMT) in HFrEF and CKD

 • Class I pillars of HFrEF GDMT across
) in HFrEF and CKD ... diuretics, MRA, SGLT2i ... Chronotropes • Medications ... used in HFrEF: ... #CKD #HFrEF #management
Heart Failure (HFrEF) Treatment - GDMT for stage C 

For patients with Heart Failure with REDUCED
Heart Failure (HFrEF ... Ejection Fraction (HFrEF ... patients with HFrEF ... #sCHF #HeartFailure ... #HFrEF #Pharmacology